The expression of YOD1 affects the proportion of immune cell immersion in the micro-environment of pancreatic tumor and they have potential therapeutic value. p53, TGF-β and especially Hippo signaling pathways may be the key pathways of YOD1 regulation. Further experimental validation should be performed to demonstrate the biological effects of YOD1. Here, YOD1 is linked to pancreatic neoplasm.